Holen Sie sich die Stockscreener-App
145.26
0.09%
0.0491
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt GILD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Gilead Sciences Inc Aktie (GILD) Neueste Nachrichten
Martingale Asset Management L P Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Invesco Ltd. Purchases 1,618,453 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
The Zacks Analyst Blog Oracle, T-Mobile, Gilead, and C&F Financial - Yahoo Finance Singapore
Stock Traders Purchase Large Volume of Call Options on Gilead Sciences (NASDAQ:GILD) - MarketBeat
HIV prevention efforts amplified through music at SXSW, Gilead Sciences asserts - Traders Union
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals - simplywall.st
Gilead Sciences, Inc. $GILD Stake Boosted by SageView Advisory Group LLC - MarketBeat
Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Bokf Na Raises Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead (NASDAQ:GILD) Institutional Focus Rises In Nasdaq 100 Index - Kalkine Media
HER2-Negative Metastatic Breast Cancer Market Expected to Transform Significantly Through 2034, According to DelveInsight | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene - StreetInsider
News | British Land and Royal London sign Gilead at Euston development - CoStar
Gilead’s US$7.8b Arcellx Deal Deepens Cell Therapy Diversification - simplywall.st
Gilead Sciences, Inc. $GILD Shares Sold by Mackenzie Financial Corp - MarketBeat
Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead at Leerink Conference: Strategic Expansion in Healthcare - Investing.com India
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained - AOL.com
Jefferies Initiates Coverage on Gilead Sciences (GILD) with 'Buy' Rating | GILD Stock News - GuruFocus
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained - 24/7 Wall St.
What 16 Analyst Ratings Have To Say About Gilead Sciences - Benzinga
Gilead Sciences (NASDAQ:GILD) Now Covered by Analysts at Jefferies Financial Group - MarketBeat
Gilead price boosted by important supportForecast today10-03-2026 - Economies.com
Gilead Sciences, Inc. $GILD Shares Sold by Richard Bernstein Advisors LLC - MarketBeat
Gilead Sciences, Inc. $GILD Stock Position Decreased by Capital Research Global Investors - MarketBeat
Gilead Sciences, Inc. $GILD Holdings Trimmed by Capital World Investors - MarketBeat
Capital International Inc. CA Raises Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Jefferies initiates Gilead Sciences stock with buy rating By Investing.com - Investing.com Canada
Legal & General Group Plc Buys 414,454 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Russell Investments Group Ltd. Sells 49,215 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Fieldview Capital Management LLC Invests $1.91 Million in Gilead Sciences, Inc. $GILD - MarketBeat
GILEAD SCIENCES INC (NASDAQ:GILD): A Durable Dividend Stock for Income Investors - ChartMill
Jefferies initiates Gilead Sciences stock with buy rating - Investing.com
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion - Insider Monkey
Banque Cantonale Vaudoise Has $8.91 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know - Yahoo Finance
How Low Can Gilead Sciences Stock Really Go? - Trefis
Swiss National Bank Has $398 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Schroder Investment Management Group Has $230.08 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by WINTON GROUP Ltd - MarketBeat
Vinva Investment Management Ltd Increases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by Kiltearn Partners LLP - MarketBeat
Natixis Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
B. Metzler seel. Sohn & Co. AG Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Citigroup Maintains Buy on GILD (Gilead Sciences, Inc.) March 2026 - Meyka
Arcellx set to report earnings amid $7.8B Gilead deal - Investing.com
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Has $2.81 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Parallel Advisors LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Korea Investment CORP Boosts Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Rhenman & Partners Asset Management AB Sells 88,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Blair William & Co. IL - MarketBeat
Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Share Price Run - Yahoo Finance
Gilead’s BIC LEN HIV Results Highlight Valuation Gap And Future Potential - Yahoo Finance
Gilead Sciences, Inc. $GILD Shares Purchased by HUB Investment Partners LLC - MarketBeat
Munich Reinsurance Co Stock Corp in Munich Takes $67.50 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
First Trust Advisors LP Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
GILD Stock Quote Price and Forecast - CNN
Is Gilead Sciences Inc. stock overvalued by current metricsWeekly Trade Review & Low Drawdown Momentum Trade Ideas - Naître et grandir
These 3 Cash Flow Machines Provide Stability in Uncertain Markets - Investing.com
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term - Yahoo Finance
BofA reiterates Gilead Sciences stock Buy rating on Yeztugo uptake - Investing.com
Gilead in talks with South Africa to start local production of new HIV therapy - Seeking Alpha
Gilead Sciences, Inc. $GILD Stock Position Lifted by Orion Porfolio Solutions LLC - MarketBeat
Kingsview Wealth Management LLC Trims Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Edgar Lomax Co. VA Has $19.46 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by Fisher Asset Management LLC - MarketBeat
South Africa seeks local production of Gilead’s HIV prevention drug - WHTC
Gilead and South Africa are negotiating a license for local production of new HIV drug - statnews.com
Stonebridge Capital Advisors LLC Sells 9,029 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now? - Yahoo Finance
South Dakota Investment Council Cuts Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Picton Mahoney Asset Management Boosts Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences stock forecast for 2030: Can $7.8B Arcellx deal push GILD to $220 with no patent cliff until 2036? - Traders Union
Crossmark Global Holdings Inc. Grows Stake in Gilead Sciences, Inc. $GILD - MarketBeat
0.32%
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):